Articles dans des revues avec comité de lecture (102)
  1. 1. Soumoy, L., Genbauffe, A., Mouchart, L., Sperone, A., Trelcat, A., Mukeba-Harchies, L., Wells, M., Blankert, B., Najem, A., Ghanem, G. E., Saussez, S., & Journé, F. (2024). ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy. Cancer cell international, 24(1), 8. doi:10.1186/s12935-023-03196-y
  2. 2. Mhaidly, N., Barake, N., Trelcat, A., Journé, F., Saussez, S., & Descamps, G. (2024). Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway. Cancers (Basel), 16(15), 2739. doi:10.3390/cancers16152739
  3. 3. Krayem, M., Najem, A., Journé, F., Morandini, R., Sales, F., Awada, A., & Ghanem, G. E. (2024). Retraction: Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma. Oncotarget, 15, 354. doi:10.18632/oncotarget.28580
  4. 4. Bouland, C., Vanden Eynden, X., Lalmand, M., Buset, T., Yanni, A., Javadian, R., Rodriguez, A., Loeb, I., Lechien, J., Journé, F., Saussez, S., & Dequanter, D. (2023). Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review. Journal of Clinical Medicine, 12(19), 6195. doi:10.3390/jcm12196195
  5. 5. Mhaidly, N., Journé, F., Najem, A., Stock, L., Trelcat, A., Dequanter, D., Saussez, S., & Descamps, G. (2023). Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell–Macrophage Interactions Using Three-Dimensional Coculture Models. International journal of molecular sciences, 24(16), 12813. doi:10.3390/ijms241612813
  6. 6. Scalia, A., Doumani, L., Kindt, N., Journé, F., Trelcat, A., & Carlier, S. (2023). The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers. Biology, 12(7), 896. doi:10.3390/biology12070896
  7. 7. Kehagias, P., Kindt, N., Krayem, M., Najem, A., Agostini, G., Acedo Reina, E., Bregni, G., Sclafani, F., Journé, F., Awada, A., Ghanem, G. E., & Hendlisz, A. (2022). Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance. Cells, 11(22), 3663. doi:10.3390/cells11223663
  8. 8. Descamps, G., Furgiuele, S., Mhaidly, N., Journé, F., & Saussez, S. (2022). Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer. Cancers (Basel), 14(22), 5560. doi:10.3390/cancers14225560
  9. 9. Scalia, A., Kindt, N., Trelcat, A., Nachtergael, A., Duez, P., Journé, F., & Carlier, S. (2022). Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells. International journal of molecular sciences, 23(20), 12552. doi:10.3390/ijms232012552
  10. 10. Marin, J., Journé, F., Ghanem, G. E., Awada, A., & Kindt, N. (2022). Cytokine Landscape in Central Nervous System Metastases. Biomedicines, 10(7), 1537. doi:10.3390/biomedicines10071537
  11. 11. Furgiuele, S., Descamps, G., Lechien, J., Dequanter, D., Journé, F., & Saussez, S. (2022). Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients. Cells, 11(13), 2050. doi:10.3390/cells11132050
  12. 12. Furgiuele, S., Descamps, G., Cascarano, L., Boucq, A., Dubois, C., Journé, F., & Saussez, S. (2022). Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers. International journal of molecular sciences, 23(12), 6385. doi:10.3390/ijms23126385
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>